Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.（CRNX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CRNX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
21
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Crinetics Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CRNX 季度内部人买卖趋势
CRNX 内幕交易卖出 · CRNX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CRNX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CRNX 高管卖出股份 · CRNX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 222,200 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 111,100 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 222,200 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 111,100 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 222,200 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 222,200 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 80,000 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 111,100 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 111,100 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 80,000 | — | Form 4 |
| May 29, 2026 | Struthers Richard Scott President & CEO · Director | Gift | 111,100 | — | Form 4 |
| Apr 8, 2026 | Knight Jeff E. Chief Dev. & Operating Officer | Option | 19,336 | $380K | Form 4 |
| Apr 8, 2026 | Knight Jeff E. Chief Dev. & Operating Officer | Option | 9,624 | $193K | Form 4 |
| Apr 8, 2026 | Knight Jeff E. Chief Dev. & Operating Officer | Option | 49,474 | $1.19M⚡ | Form 4 |
| Apr 8, 2026 | Knight Jeff E. Chief Dev. & Operating Officer | Sale | 85,163 | $3.42M⚡ | Form 4 |
| Mar 16, 2026 | Knight Jeff E. COO | Sale | 5,950 | $221K | Form 4 |
| Mar 16, 2026 | Knight Jeff E. COO | Sale | 3,961 | $150K | Form 4 |
| Mar 16, 2026 | Betz Stephen F. Chief Scientific Officer | Sale | 6,371 | $236K | Form 4 |
| Mar 16, 2026 | Betz Stephen F. Chief Scientific Officer | Sale | 4,241 | $160K | Form 4 |
| Mar 16, 2026 | Struthers Richard Scott President & CEO · Director | Sale | 13,196 | $490K | Form 4 |
| Mar 16, 2026 | Struthers Richard Scott President & CEO · Director | Sale | 8,785 | $332K | Form 4 |
| Mar 12, 2026 | Vivaldi Coelho Rogerio Director | Sale | 4,477 | $162K | Form 4 |
| Mar 12, 2026 | Vivaldi Coelho Rogerio Director | Sale | 523 | $19K | Form 4 |
| Mar 3, 2026 | Okey Stephanie Director | Sale | 3,000 | $119K | Form 4 |
| Mar 3, 2026 | Schilke Tobin CFO | Sale | 6,713 | $266K | Form 4 |
Knight Jeff E.
Chief Dev. & Operating Officer
日期
Apr 8
股数
19,336
均价
$19.64
总金额
$380K
Knight Jeff E.
Chief Dev. & Operating Officer
日期
Apr 8
股数
9,624
均价
$20.02
总金额
$193K
Knight Jeff E.
Chief Dev. & Operating Officer
日期
Apr 8
股数
49,474
均价
$23.98
总金额
$1.19M ⚡
Knight Jeff E.
Chief Dev. & Operating Officer
日期
Apr 8
股数
85,163
均价
$40.10
总金额
$3.42M ⚡
Struthers Richard Scott
President & CEO · Director
日期
Mar 16
股数
13,196
均价
$37.11
总金额
$490K
Struthers Richard Scott
President & CEO · Director
日期
Mar 16
股数
8,785
均价
$37.77
总金额
$332K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CRNX 内幕交易
CRNX 内幕交易
Crinetics Pharmaceuticals, Inc.（CRNX）内幕交易数据来源于公司内部人（包括Struthers Richard Scott (President & CEO · Director), Pizzuti Dana (Chief Med and Dev Officer), Knight Jeff E. (Chief Dev. & Operating Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CRNX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Crinetics Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CRNX 内幕交易 · 5个问题Crinetics Pharmaceuticals, Inc.（CRNX）的内部人包括高管和董事，如Struthers Richard Scott (President & CEO · Director), Pizzuti Dana (Chief Med and Dev Officer), Knight Jeff E. (Chief Dev. & Operating Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026